home

Overview - SLGL US

Sol Gel Technologies Ltd
SLGL.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat rare hyperkeratinization disorders, such as Darier, PC, PPK, Olmsted, etc. In addition, the company is also involved in the development of generic topical dermatological drug products. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
symbollastchange%chngnamemcapsectorwiki
SLGL Sol Gel Technologies Ltd 0.027B Healthcare

symbolprev.closerangecharttargetpercentperiodmonthsduerating
 D  SLGL 0.89 0,-1.600,-1.354,0.030,-1.600 1.14,1.15,1.34,1.27,1.19,1.13,1.09,1.07,1.06,1.01,0.98,1.01,0.85,0.90,0.91 0.83-1.23 15.62% 267,114,267 5.1 Jan 5-Sep 28 41.66%
Intraday chart for SLGL

Please reload the page if latest figures not showing

The following extracted figures are selected by the AI as the most essential for predicting future price movements. The arrows show the how the AI thinks the figure affects the stock price (not the change in the figure)

. operatingIncome -5M  
. . netInterestIncome 1M
. incomeBeforeTax -5M  
. otherOperatingExpenses 6M  
. netIncomeApplicableToCommonShares  
. reconciledDepreciation  
. netWorkingCapital 37M
. netInvestedCapital 39M  
. netDebt -6M  
. totalCashFromOperatingActivities  
. freeCashFlow. .  

Chart SLGL

Casper Sleep Inc CSPR US Consumer Cyclical 62.2833 282M -
SmileDirectClub Inc SDC US Healthcare 68.6683 29M -
Sol Gel Technologies Ltd SLGL US Healthcare 57.4101 27M -

Myshare aims to provide good clear honest and easy analysis of financial markets using a scientific, teaching and informative approach. We try hard but please read our disclaimer. Pages are provided by ourselves and our users. Register to edit pages and see the documentation

Global news | headline news | recent news | latest news | market news | topics | stock topics

News topics and stories from around the world and in the selected country

US News | headline news | recent news | latest news | market news | recent topics | stock topics

News from major news outlets like BBC, CNN and Reuters

Forecasts | Forecast buy | Forecast sell | Forecast up | Forecast down | Forecast sector

Long term stock predictions using AI reading the financial accounts of each company.

Ai Predictions | Buys | All up | sell | all down | forecast | History

``` ``` ``` ```